BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Marksans Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (Rs)
30.5295026
NSE Symbol
MARKSANS
Divident Yield %
0.31
Market Cap
(Rs In Cr.)
11,744
P/E (TTM)
62.45
EPS (TTM)
4.15
Face Value
(Rs)
1
Back
Relonchem receives marketing authorization for Gabapentin 50 mg/ml oral solution
15-May-25   Hrs IST

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)